Jeffrey Stavenhagen
Company: Dianthus Therapeutics
Job title: Chief Scientific Officer
Seminars:
From Bench to Bedside: Streamlining Preclinical Strategies for Effective Complement Drug Development Across Disease Indications 12:30 pm
A comprehensive guide to improving the efficacy measurement and translational success of complement inhibitors. Explore cutting-edge methodologies and best practices in preclinical research to bridge the gap between laboratory findings and clinical application. Conduct detailed dose-response studies to determine the optimal dosing regimen that maximizes efficacy while minimizing toxicity Perform extensive safety and toxicology studies…Read more
day: Pre-Conference Workshop Day